Designation supports the global development of RTX-117 and may provide potential future access to a transferable Priority ...

New paradigm integrates single-cell transcriptomics, regulatory network inference, and AI to decode—and therapeutically ...

Biosidus, an Argentine biotechnology company with more than four decades of experience in the development and manufacturing ...

EMPAD G2 enables high-speed four-dimensional scanning transmission electron microscopy (4D STEM), an advanced form of ...

Expanded agreement will integrate MAGENTIQ-COLO into PENTAX Medical’s INSPIRA and IMAGINA endoscopy platforms, extending clinically validated AI-assisted polyp detection across the US, EMEA, JAPAC and ...

Monod Bio's LuxSit is an AI-designed luciferase engineered for use in robust luminescent biosensors, while its NovoBodies are ...

Multi-country projects across Africa and Asia leverage alternative sample collection and advanced metabolomics to accelerate ...

U.S. IRB Approval for Pivotal Phase 3 Trial SUPREME-01 (CBL-0301)—The protocol amendment for the pivotal Phase 3 clinical ...

First-in-human KOALA study evaluates tumour-specific KMCAR T-cell therapy in relapsed/refractory multiple myeloma, aiming to ...

Figure 1. Regulatory classification of biological age test categories against market, as at 17 August 2026. Cells record the ...

Phase 3 HERIZON-GEA-01 regimen delivers median overall survival of 26.4 months in advanced or metastatic HER2-positive ...

The Group's gross profit increased by 40.6 % period-over-period to RMB 1,371.3 million, with a gross profit margin of 37.0 % ...